» Articles » PMID: 1431141

The Proteoglycan Decorin Binds C1q and Inhibits the Activity of the C1 Complex

Overview
Journal J Immunol
Date 1992 Dec 1
PMID 1431141
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Decorin, a small collagen-binding dermatan sulfate proteoglycan, is widely distributed as a component of extracellular matrices. Using a solid phase binding assay, we showed that decorin bound C1q at physiologic pH and ionic strength. The interaction did not require divalent cations and was time and temperature dependent reaching equilibrium in 4 h at 37 degrees C. Binding was specific and saturable with an apparent dissociation constant of 7.6 x 10(-9) M. Decorin was shown to bind pepsin-derived fragments containing the collagenous domain of C1q and collagenase-derived fragments containing the globular domain of C1q. Because these fragments share a short sequence of amino acids, this finding suggests that decorin binds to a region of C1q located near the junction of the two domains. Competition studies using purified preparations of the decorin core protein and the glycosaminoglycan chains showed that only the former inhibited binding of decorin to C1q indicating that the interaction is mediated by the decorin core protein. Decorin was shown to inhibit the hemolytic activity of purified C1 as well as C1 in normal human serum. Approximately 50% inhibition was observed at a decorin concentration of 2 micrograms/ml. Inhibition was not observed if C1 was bound to Ag-complexed antibody. Furthermore, neither the core protein nor the glycosaminoglycan chain of decorin inhibited C1, indicating that the intact proteoglycan is necessary for functional activity.

Citing Articles

Collagen Binding Proteins of Gram-Positive Pathogens.

Arora S, Gordon J, Hook M Front Microbiol. 2021; 12:628798.

PMID: 33613497 PMC: 7893114. DOI: 10.3389/fmicb.2021.628798.


Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.

Mellors J, Tipton T, Longet S, Carroll M Front Immunol. 2020; 11:1450.

PMID: 32733480 PMC: 7363932. DOI: 10.3389/fimmu.2020.01450.


Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.

Lee H, Jang Y Int J Mol Sci. 2018; 19(3).

PMID: 29498630 PMC: 5877572. DOI: 10.3390/ijms19030711.


Osteoarthritis and the Complement Cascade.

Silawal S, Triebel J, Bertsch T, Schulze-Tanzil G Clin Med Insights Arthritis Musculoskelet Disord. 2018; 11:1179544117751430.

PMID: 29434479 PMC: 5805003. DOI: 10.1177/1179544117751430.


Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Abou-El-Hassan H, Zaraket H Exp Biol Med (Maywood). 2016; 242(4):397-410.

PMID: 27798122 PMC: 5298540. DOI: 10.1177/1535370216675772.